Cartesian Therapeutics (RNAC) Exchange Rate Effect (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Exchange Rate Effect of -$7000.0 for Q1 2026, down 121.88% year-over-year from $32000.0 in Q1 2025, and down 163.64% quarter-over-quarter from $11000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Exchange Rate Effect data on file, last reported at -$7000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$7000.0, down 121.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $6000.0 (down 62.5% YoY), and the FY2025 annual result was $45000.0, up 314.29% from the prior year.
- Exchange Rate Effect fell to -$7000.0 in Q1 2026 per RNAC's latest filing, from $11000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $115000.0 in Q2 2022 and troughed at -$45000.0 in Q4 2022.
- A 5-year average of -$941.18 and a median of -$10000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect plunged 650.0% in 2022, then surged 740.0% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$45000.0 in 2022, then jumped by 135.56% to $16000.0 in 2023, then slumped by 193.75% to -$15000.0 in 2024, then jumped by 173.33% to $11000.0 in 2025, then plunged by 163.64% to -$7000.0 in 2026.
- Business Quant data shows RNAC's Exchange Rate Effect at -$7000.0 in Q1 2026, $11000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | -7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |